COL4A3BP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.720400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.817400E-01
Normal-vs-Stage2
6.027600E-01
Normal-vs-Stage3
2.807900E-02
Normal-vs-Stage4
8.953400E-01
Stage1-vs-Stage2
1.627400E-01
Stage1-vs-Stage3
1.493810E-02
Stage1-vs-Stage4
7.592600E-01
Stage2-vs-Stage3
2.563200E-04
Stage2-vs-Stage4
4.396000E-01
Stage3-vs-Stage4
6.069600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.784600E-01
Normal-vs-AfricanAmerican
8.074000E-01
Normal-vs-Asian
1.643190E-01
Caucasian-vs-AfricanAmerican
2.554600E-01
Caucasian-vs-Asian
3.833800E-02
AfricanAmerican-vs-Asian
7.728400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.175400E-01
Normal-vs-Female
6.308400E-01
Male-vs-Female
6.649800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.923200E-01
Normal-vs-Age(41-60Yrs)
8.962200E-01
Normal-vs-Age(61-80Yrs)
4.919400E-01
Normal-vs-Age(81-100Yrs)
3.595400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.289000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.488000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.754400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.895100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.803600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.094200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.862230E-01
Normal-vs-Daily Drinker
3.881800E-01
Normal-vs-Weekly Drinker
1.732030E-01
Normal-vs-Occasional Drinker
8.218400E-01
Normal-vs-Social Drinker
8.666600E-01
Non Drinker-vs-Daily Drinker
4.006400E-01
Non Drinker-vs-Weekly Drinker
7.765000E-01
Non Drinker-vs-Occasional Drinker
5.499800E-03
Non Drinker-vs-Social Drinker
9.268200E-02
Daily Drinker-vs-Weekly Drinker
3.478800E-01
Daily Drinker-vs-Occasional Drinker
5.480400E-02
Daily Drinker-vs-Social Drinker
3.399200E-01
Weekly Drinker-vs-Occasional Drinker
1.698170E-02
Weekly Drinker-vs-Social Drinker
1.331360E-01
Occasional Drinker-vs-Social Drinker
4.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.059990E-01
Normal-vs-Grade 2
1.506010E-02
Normal-vs-Grade 3
5.903400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.071400E-01
Grade 1-vs-Grade 3
8.094400E-01
Grade 1-vs-Grade 4
1.059990E-01
Grade 2-vs-Grade 3
9.957400E-01
Grade 2-vs-Grade 4
1.506010E-02
Grade 3-vs-Grade 4
5.903400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.109000E-01
Normal-vs-NonDiabetic
5.327800E-01
Diabetic-vs-NonDiabetic
8.843000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.647600E-01
Normal-vs-NoPancreatitis
5.946800E-01
Pancreatitis-vs-NoPancreatitis
3.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.418400E-01
Normal-vs-N1
6.204800E-01
N0-vs-N1
8.251800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.091600E-01
Normal-vs-TP53-NonMutant
8.517600E-01
TP53-Mutant-vs-TP53-NonMutant
2.418800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
